Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Nemus Bioscience Adds to Senior Leadership Team
May 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
LONG BEACH, CA, May 07, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
Nemus Secures Emerald Health as Strategic Majority Investor to help Advance Clinical Development of Novel Cannabinoid-based Therapeutics
January 19, 2018 08:30 ET
|
Nemus Bioscience, Inc.
Nemus Bioscience Receives $400,000 Funding under Convertible Bridge Loan and Closes Initial $1,500,000 Private Placement COSTA MESA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc....
Nemus Bioscience Announces Closing of Convertible Bridge Loan and Anticipated Equity Financing
December 29, 2017 08:30 ET
|
Nemus Bioscience, Inc.
COSTA MESA, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS, “Nemus”) today announced that it entered into agreements with Emerald Health Sciences Inc. (“Emerald”),...
NEMUS Bioscience, Inc. Retains MZ Group as Investor Relations Advisor
March 24, 2015 07:08 ET
|
Nemus Bioscience
COSTA MESA, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- NEMUS Bioscience Inc. (OTCQB: NMUS), a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities...
NEMUS Bioscience, Inc. initiates anti-infective program with focus on MRSA
March 18, 2015 07:06 ET
|
Nemus Bioscience
COSTA MESA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS) announced today that the company would begin studies concerning the medical utility of cannabinoids as...